<DOC>
	<DOCNO>NCT00156572</DOCNO>
	<brief_summary>Hydrochlorothiazide spironolactone diuretic commonly preterm infant bronchopulmonary dysplasia ( BPD ) . Hyponatremia ( low blood salt ) common side effect . It uncertain whether best way treat hyponatremia oral salt supplementation restrict fluid intake . Our hypothesis fluid restrict infant well able preserve beneficial effect diuretic lung . The study include low birth weight infant ( VLBW ) 400-1500g Hermann Memorial Children 's Hospital NICU LBJ General Hospital NICU BPD . They enrol randomly assign either salt supplementation group fluid restriction group become hyponatremic ( defined serum Na &lt; 130 ) . The study intervention take place four week . The primary outcome assess compare patient 's initial oxygen breathing machine requirement end four-week study period .</brief_summary>
	<brief_title>Management Hyponatremia Preterm Infants Diuretics</brief_title>
	<detailed_description>Study Question : Among low birth weight infant , 400-1500 g , bronchopulmonary dysplasia develop hyponatremia receive hydrochlorothiazide diuretic : oral sodium supplementation compare fluid restriction affect FiO2 requirement ( change Respiratory Index Score [ RIS ] Ventilated CPAP baby , change FiO2 spontaneously breathe baby ) four week ? Randomization Method : Enrolled patient randomly assign either sodium supplementation group fluid restriction group become hyponatremic ( serum sodium &lt; 130 ) take hydrochlorothiazide . Interventions : Sodium Supplementation : Patients randomize sodium supplementation group receive oral NaCl add feed . When serum sodium 125-130 , 2 meq/kg/day NaCl add feed . If serum sodium 120-124 , 4 meq/kg/day NaCl add feed . Na supplementation continue serum Na &gt; 135 . Fluid Restriction : Patients randomize fluid restriction group fluid intake decrease 20cc/kg/day . In order maintain approximately caloric intake , 0.5 cc/kg/dose corn oil ( 8.4kcal/cc ) , administer bolus every 6 hour . If fluid restriction n't increase serum sodium 130 within one week serum Na 120-124 infant receive &gt; 140 cc/kg/d , fluid intake decrease additional 10cc/kg/day one additional week . Outcome Assessments Primary Outcome - change FiO2/RIS baseline outcome 4 week enrollment . Secondary Outcomes 1 . 24-hour urine sodium , calcium , creatinine 4 week . 2 . The mean serum Na+ nadir group . 3 . The mean serum K+ nadir group . 4 . Time extubation infant ventilate enrollment . 5 . Time CPAP mechanical ventilation infant CPAP enrollment . Sample Size : The estimated sample size study 58 , base effect size 10 % mean FiO2 40 % ( 0.1 x 40= 4 % absolute difference ) , expect standard deviation 5 % FiO2 , alpha ( two-sided ) = 0.05 ; Beta = 1 - 0.80 = 0.20 . Analysis : The follow analysis plan design allow every randomized infant include analysis ( intention-to-treat analysis ) regardless whether intubate , extubated , take put onto CPAP , die course 4-week study period . All infant ( study group combine ) assign rank baseline outcome ( 4 week ) within follow subgroup : infant O2 oxyhood , infant nasal cannula , infant CPAP , infant ventilator , infant die study . For infant , change rank ( outcome minus baseline ) calculate . The change rank compare two study group use non-parametric test .</detailed_description>
	<mesh_term>Hyponatremia</mesh_term>
	<mesh_term>Bronchopulmonary Dysplasia</mesh_term>
	<mesh_term>Diuretics</mesh_term>
	<criteria>1 . Very low birth weight infant , 4001500 gram 2 . Bronchopulmonary dysplasia define oxygen requirement great 30 % 4 week age chest xray finding consistent develop chronic lung disease . 3 . Receiving 120kcal/kg/d enterally fortified human milk 24 kcal/oz formula 4 . Hyponatremic ( define serum Na &lt; 130 ) . 1 . Known congenital anomaly involve heart , lung , kidney , chromosomal abnormality . 2 . Creatinine â‰¥ 1.3 . 3 . Enteral ostomy .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>6 Months</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>